デフォルト表紙
市場調査レポート
商品コード
949386

ヒトマイクロバイオーム (微生物叢) の世界市場:2019年~2025年

Global Human Microbiome Market 2019-2025

出版日: | 発行: Orion Market Research Pvt Ltd | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.41円
ヒトマイクロバイオーム (微生物叢) の世界市場:2019年~2025年
出版日: 2020年05月12日
発行: Orion Market Research Pvt Ltd
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヒトマイクロバイオーム (微生物叢) 市場は、予測期間中にかなりの成長が見込まれています。市場は、疾患の早期発見・診断に対するマイクロバイオーム (微生物叢) シーケンシングへの継続的な関心の高まりなど、数多くの要因によって促進されています。

当レポートでは、世界のヒトマイクロバイオーム (微生物叢) 市場について調査分析し、市場概要、セグメント別の市場分析、地域別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 レポートサマリー

第2章 市場概要と考察

  • レポートの範囲
  • アナリストの考察と現在の市場動向
  • 規則と規制

第3章 競合情勢

  • 企業シェア分析
  • 主要戦略分析
  • 主要企業分析

第4章 市場決定要因

  • 促進要因
  • 抑制要因
  • 機会

第5章 市場セグメンテーション

  • 世界のヒトマイクロバイオーム (微生物叢) 市場:製品タイプ別
    • プロバイオティクス
    • プレバイオティクス
    • 医療食品
    • 医薬品
    • その他(診断検査)
  • 世界のヒトマイクロバイオーム (微生物叢) 市場:疾患別
    • がん
    • 胃腸障害
    • 感染症
    • 糖尿病
    • その他(神経疾患)
  • 世界のヒトマイクロバイオーム (微生物叢) 市場:技術別
    • ゲノミクス
    • プロテオミクス
    • メタボロミクス

第6章 地域別分析

  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域

第7章 企業プロファイル

  • 4D pharma PLC
  • BiomX Inc.
  • DuPont de Nemours, Inc.
  • Enterome SA
  • Evelo Biosciences, Inc.
  • Ferring International Center S.A.
  • Illumina Inc.
  • Kaleido Biosciences, Inc.
  • LNC Therapeutics
  • Molzym GmbH & Co. KG
  • Novogene Corp.
  • OptiBiotix Health PLC
  • Qiagen NV
  • Rebiotix Inc.
  • Ritter Pharmaceuticals, Inc.
  • Second Genome Inc.
  • Seres Therapeutics, Inc.
  • Thermo Fisher Scientific Inc.
  • uBiome Inc.
  • Vedanta Biosciences, Inc.
図表

LIST OF TABLES

  • 1. GLOBAL HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 2. GLOBAL HUMAN MICROBIOME PROBIOTICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL HUMAN MICROBIOME PREBIOTICS RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL HUMAN MICROBIOME MEDICAL FOODS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL HUMAN MICROBIOME DRUGS RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL OTHER HUMAN MICROBIOME PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY DISEASE, 2018-2025 ($ MILLION)
  • 8. GLOBAL HUMAN MICROBIOME FOR CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBAL HUMAN MICROBIOME FOR GASTROINTESTINAL DISORDER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBAL HUMAN MICROBIOME FOR INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBAL HUMAN MICROBIOME FOR DIABETES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 12. GLOBAL HUMAN MICROBIOME FOR OTHER DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 13. GLOBAL HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 14. GLOBAL HUMAN MICROBIOME GENOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 15. GLOBAL HUMAN MICROBIOME PROTEOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 16. GLOBAL HUMAN MICROBIOME METABOLOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 17. GLOBAL HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 18. NORTH AMERICAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 19. NORTH AMERICAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 20. NORTH AMERICAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY DISEASE, 2018-2025 ($ MILLION)
  • 21. NORTH AMERICAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 22. EUROPEAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 23. EUROPEAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 24. EUROPEAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY DISEASE, 2018-2025 ($ MILLION)
  • 25. EUROPEAN HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 26. ASIA-PACIFIC HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 27. ASIA-PACIFIC HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 28. ASIA-PACIFIC HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY DISEASE, 2018-2025 ($ MILLION)
  • 29. ASIA-PACIFIC HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)
  • 30. REST OF THE WORLD HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY PRODUCT TYPE, 2018-2025 ($ MILLION)
  • 31. REST OF THE WORLD HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY DISEASE, 2018-2025 ($ MILLION)
  • 32. REST OF THE WORLD HUMAN MICROBIOME MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL HUMAN MICROBIOME MARKET SHARE BY PRODUCT TYPE, 2018 VS 2025 (%)
  • 2. GLOBAL HUMAN MICROBIOME MARKET SHARE BY DISEASE, 2018 VS 2025 (%)
  • 3. GLOBAL HUMAN MICROBIOME MARKET SHARE BY TECHNOLOGY, 2018 VS 2025 (%)
  • 4. GLOBAL HUMAN MICROBIOME MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 5. US HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. CANADA HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. UK HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. FRANCE HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. GERMANY HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. ITALY HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. SPAIN HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. ROE HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. INDIA HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. CHINA HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. JAPAN HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
  • 17. REST OF THE WORLD HUMAN MICROBIOME MARKET SIZE, 2018-2025 ($ MILLION)
目次
Product Code: OMR2021704

Global Human Microbiome Market Size, Share & Trends Analysis Report by Product Type (Probiotics, Prebiotics, Medical Foods, Drugs, and Others), by Disease (Cancer, Gastrointestinal Disorder, Infetious Diseases, Diabetes, and Others) and by Technology (Genomics, Proteomics, and Metabolomics) and Forecast 2019-2025

The global human microbiome market is projected to witness considerable growth during the forecast period. The human microbiome market is driven by numerous factors such as continuous increasing focus on microbiome sequencing for early detection and diagnosis of diseases. Furthermore, numerous market players are engaging in collaborating AI with human microbiome sequencing to promote studies on gut microbiomes. However, as microbiome sequencing technology is an upcoming technology, a lack of skilled labor is one of the key factors which can have a negative impact on the growth of the market. The human microbiome market is classified on the basis of product type, disease, and technology. Based on product type, the market is segmented into probiotics, prebiotics, medical foods, drugs, and others. Based on disease, the market is segmented into cancer, gastrointestinal disorder, infectious diseases, diabetes, and others. Based on technology, the market is segmented into genomics, proteomics, and metabolomics.

Geographically, the global human microbiome market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to contribute a significant share in the global market. The growth factor of the region includes the presence of numerous key players, such as Illumina, Inc. and increasing government spending for microbiome research in the US. NIH and Canadian institutes of health are the two key institutes which are investing in the R&D of microbiomes study across North America. Developed healthcare infrastructure and significant government healthcare spending is promoting R&D of such advanced technology across the region thereby promoting the growth of the market in the near future.

The global human microbiome market is influenced by product development and advancements conducted by the market players. The key players of the human microbiome market include Illumina Inc., Vedanta Biosciences, Inc., Novogene Corp., Qiagen NV, and Thermo Fisher Scientific Inc. These players are playing a significant role in the growth of the human microbiome market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the global human microbiome market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Human Microbiome Market Research and Analysis by Product Type

2. Global Human Microbiome Market Research and Analysis by Disease

3. Global Human Microbiome Market Research and Analysis by Technology

The Report Covers:

  • Comprehensive research methodology of the global human microbiome market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global human microbiome market.
  • Insights about market determinants which are stimulating the global market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Illumina Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Vedanta Biosciences, Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Novogene Corp.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Qiagen NV
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Thermo Fisher Scientific Inc.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Human Microbiome Market by Product Type
    • 5.1.1. Probiotics
    • 5.1.2. Prebiotics
    • 5.1.3. Medical Foods
    • 5.1.4. Drugs
    • 5.1.5. Others (Diagnostic Tests)
  • 5.2. Global Human Microbiome Market by Disease
    • 5.2.1. Cancer
    • 5.2.2. Gastrointestinal Disorder
    • 5.2.3. Infectious Diseases
    • 5.2.4. Diabetes
    • 5.2.5. Others (Neurological Disorder)
  • 5.3. Global Human Microbiome Market by Technology
    • 5.3.1. Genomics
    • 5.3.2. Proteomics
    • 5.3.3. Metabolomics

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. 4D pharma PLC
  • 7.2. BiomX Inc.
  • 7.3. DuPont de Nemours, Inc.
  • 7.4. Enterome SA
  • 7.5. Evelo Biosciences, Inc.
  • 7.6. Ferring International Center S.A.
  • 7.7. Illumina Inc.
  • 7.8. Kaleido Biosciences, Inc.
  • 7.9. LNC Therapeutics
  • 7.10. Molzym GmbH & Co. KG
  • 7.11. Novogene Corp.
  • 7.12. OptiBiotix Health PLC
  • 7.13. Qiagen NV
  • 7.14. Rebiotix Inc.
  • 7.15. Ritter Pharmaceuticals, Inc.
  • 7.16. Second Genome Inc.
  • 7.17. Seres Therapeutics, Inc.
  • 7.18. Thermo Fisher Scientific Inc.
  • 7.19. uBiome Inc.
  • 7.20. Vedanta Biosciences, Inc.